Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis ; volume:26 ; number:1 ; day:1 ; month:3 ; year:2024 ; pages:1-13 ; date:12.2024
Breast cancer research ; 26, Heft 1 (1.3.2024), 1-13, 12.2024
- Urheber
-
Smoots, Stephen G.
Schreiber, Anna R.
Jackson, Marilyn M.
Bagby, Stacey M.
Dominguez, Adrian T A.
Dus, Evan D.
Binns, Cameron A.
MacBeth, Morgan
Whitty, Phaedra A.
Diamond, Jennifer R.
Pitts, Todd M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-024-01799-5
- URN
-
urn:nbn:de:101:1-2405052143579.528798476743
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smoots, Stephen G.
- Schreiber, Anna R.
- Jackson, Marilyn M.
- Bagby, Stacey M.
- Dominguez, Adrian T A.
- Dus, Evan D.
- Binns, Cameron A.
- MacBeth, Morgan
- Whitty, Phaedra A.
- Diamond, Jennifer R.
- Pitts, Todd M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Yo I El Peshkado "Oki Oki"
Yo I El Peshkado "Oki Oki"
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Overcoming RAD18-mediated temozolomide resistance in glioma cells by class I HDAC inhibition
Itaru Oki : Portrait des Jazzmusikers Itaru Oki
OKiN
OKiR
ZiOKi"
?OKiR?
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Kanagawa oki nami ura
Yo I El Peshkado "Oki Oki"
Yo I El Peshkado "Oki Oki"
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Overcoming RAD18-mediated temozolomide resistance in glioma cells by class I HDAC inhibition
Itaru Oki : Portrait des Jazzmusikers Itaru Oki
OKiN
OKiR
ZiOKi"
?OKiR?
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Kanagawa oki nami ura
Yo I El Peshkado "Oki Oki"
Yo I El Peshkado "Oki Oki"
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Overcoming RAD18-mediated temozolomide resistance in glioma cells by class I HDAC inhibition
Itaru Oki : Portrait des Jazzmusikers Itaru Oki
OKiN
OKiR
ZiOKi"
?OKiR?
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer